Copyright
©The Author(s) 2015.
World J Surg Proced. Jul 28, 2015; 5(2): 187-197
Published online Jul 28, 2015. doi: 10.5412/wjsp.v5.i2.187
Published online Jul 28, 2015. doi: 10.5412/wjsp.v5.i2.187
Prognostic factors | χ2 | P value | HR | 95%CI | |
Sex male vs female | 0.263 | 0.60752 | 0.9218 | 0.676 | 1.257 |
CC score: complete vs incomplete | 4.03 | 0.04468 | 1.504 | 1.01 | 2.24 |
Nodal involvement: N0-1 vs N2-3 | 0.445 | 0.50454 | 1.1338 | 0.784 | 1.639 |
Neoadjuvant chemo.: negative vs positive | 2.517 | 0.11259 | 1.3445 | 0.933 | 1.938 |
PCI: ≤ 6 vs≥ 7 | 8.809 | 0.00299 | 1.7863 | 1.218 | 2.621 |
HIPEC: Not done vs done | 8.218 | 0.00414 | 0.6322 | 0.462 | 0.865 |
Histilogicl effects: EF 0-1 vs EF 2-3 | 12.305 | 0.00045 | 0.469 | 0.307 | 0.716 |
Cytology: Negative vs positive | 8.2163 | 0.00415 | 1.8458 | 1.213 | 2.806 |
- Citation: Yonemura Y, Canbay E, Endou Y, Ishibashi H, Mizumoto A, Li Y, Liu Y, Takeshita K, Ichinose M, Takao N, Saitou T, Noguchi K, Hirano M, Glehen O, Brűcher B, Sugarbaker PH. Comprehensive treatment for the peritoneal metastasis from gastric cancer. World J Surg Proced 2015; 5(2): 187-197
- URL: https://www.wjgnet.com/2219-2832/full/v5/i2/187.htm
- DOI: https://dx.doi.org/10.5412/wjsp.v5.i2.187